News list for "bonnet"

Bonnet BioTherapeutics与Rorschach I LLC合并为Hyperliquid Strategies

Nasdaq-listed Sonnet BioTherapeutics, Inc. has agreed to merge with Rorschach I LLC to form Hyperliquid Strategies, Inc., which will initiate a HYPE reserve strategy. Upon completion of the transaction, the new entity is expected to hold 12.60 million HYPE tokens and $305 million in cash for a total valuation of $888 million.

clock
2025-07-14 11:22:49
Bonnet BioTherapeutics与Rorschach I LLC合并为Hyperliquid Strategies

纳斯达克上市公司 Sonnet BioTherapeutics, Inc. 已同意与 Rorschach I LLC 合并成为 Hyperliquid Strategies, Inc.,该公司将启动HYPE储备策略,交易完成后新实体预计将持有 1260 万个 HYPE 代币和 3.05 亿美元现金,总估值为 8.88 亿美元。

clock
2025-07-14 11:22:49
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.